GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 327 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $570,000 | -19.5% | 4,925 | +13.9% | 1.16% | +73.5% |
| Q2 2019 | $708,000 | -2.7% | 4,325 | 0.0% | 0.67% | +13.7% |
| Q1 2019 | $728,000 | +68.9% | 4,325 | -2.3% | 0.59% | +38.2% |
| Q4 2018 | $431,000 | +1.9% | 4,425 | +80.6% | 0.43% | +17.6% |
| Q3 2018 | $423,000 | +67.9% | 2,450 | +11.4% | 0.36% | +36.0% |
| Q2 2018 | $252,000 | – | 2,200 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 602,047 | $61,102,000 | 6.76% |
| FT Options LLC | 36,847 | $3,740,000 | 5.64% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,988,019 | $303,254,000 | 4.80% |
| FT Options LLC | 71,000 | $1,320,000 | 1.99% |
| Rock Springs Capital Management LP | 373,000 | $37,856,000 | 1.75% |
| Redmile Group, LLC | 338,536 | $34,358,000 | 1.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 362,724 | $36,813,000 | 1.66% |
| Ghost Tree Capital, LLC | 50,000 | $5,075,000 | 1.08% |
| Atika Capital Management LLC | 32,500 | $3,298,000 | 0.95% |
| Sivik Global Healthcare LLC | 25,000 | $2,537,000 | 0.86% |